RxDoctor Payments Data

Christopher Thompson, PA

Physician Assistant · Glen Morgan, WVNPI 1558730721

Payments from drug & device makers

$1,443in general payments, 2019–2025

Across 80 payments — averaging $18.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$463
  • Lilly USA, LLC$374
  • AbbVie$252
  • Novo Nordisk$76
  • Xeris Pharmaceuticals, Inc.$40
  • GSK$40
  • plus $197 from 10 others

What the payments were for

  • Food & beverage$1,443100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,443 in reported general payments places this provider in the 80th percentile of 833 physician assistant providers in West Virginia.

See all physician assistant providers in West Virginia

Medicare billing

Part B allowed, 2024
$35,823
Medicare patients
142
Services billed
557

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban100$121,610
Trelegy ElliptaFluticasone/Umeclidin/Vilanter91$85,799
OzempicSemaglutide60$82,362
TrulicityDulaglutide56$73,297
FarxigaDapagliflozin Propanediol52$71,873
MounjaroTirzepatide40$50,825
JardianceEmpagliflozin18$29,521
Tresiba Flextouch U-200Insulin Degludec30$24,139
XareltoRivaroxaban14$19,561
JanuviaSitagliptin Phosphate11$18,281
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr28$13,079
Breztri AerosphereBudesonide/Glycopyr/Formoterol20$12,655
LinzessLinaclotide13$10,180
Fenofibrate22$9,518
Albuterol Sulfate HfaAlbuterol Sulfate247$6,247

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$374$124,12296 claims
PfizerEliquis$26$121,610100 claims
GSKTrelegy Ellipta, Anoro Ellipta$40$98,878119 claims
AstraZenecaFarxiga, Breztri Aerosphere$463$84,52872 claims
Novo NordiskOzempic$76$82,36260 claims
Boehringer IngelheimJardiance$39$29,52118 claims
AbbVieLinzess, Synthroid$252$11,96032 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 833 physician assistant providers in West Virginia.

Other physician assistant in Glen Morgan

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →